A novel bivalent fusion vaccine induces broad immunoprotection against Staphylococcus aureus infection in different murine models
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 188, 85-93
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31370932, 31600745, 31400792, 81501722)
This publication has 39 references indexed in Scilit:
- IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infectionMedical Microbiology and Immunology, 2017
- Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus InfectionsTrends in Pharmacological Sciences, 2016
- Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis ofStaphylococcus aureusmegaclustersJournal of Orthopaedic Research, 2014
- Opsonophagocytic Assay2013
- Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic SurgeryJAMA, 2013
- Exploring Staphylococcus aureus pathways to disease for vaccine developmentSeminars in Immunopathology, 2011
- Development of a vaccine against Staphylococcus aureusSeminars in Immunopathology, 2011
- Staphylococcal Vaccines and ImmunotherapiesInfectious Disease Clinics of North America, 2009
- Clinical Trial of Safety and Efficacy of IHN-A21 for the Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature InfantsThe Journal of Pediatrics, 2007
- Staphylococcal vaccines and immunotherapy: to dream the impossible dream?Current Opinion in Pharmacology, 2006